Gene: EEPD1
Official Full Name: endonuclease/exonuclease/phosphatase family domain containing 1provided by HGNC
Gene Summary: Predicted to enable DNA binding activity and catalytic activity. Involved in positive regulation of cholesterol efflux. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09307 | EEPD1 Knockout cell line (HeLa) | Human | EEPD1 | 1:3~1:6 | Negative | Online Inquiry |
KO09308 | EEPD1 Knockout cell line (HCT 116) | Human | EEPD1 | 1:2~1:4 | Negative | Online Inquiry |
KO09309 | EEPD1 Knockout cell line (HEK293) | Human | EEPD1 | 1:3~1:6 | Negative | Online Inquiry |
KO09310 | EEPD1 Knockout cell line (A549) | Human | EEPD1 | 1:3~1:4 | Negative | Online Inquiry |
EEP-D1 Gene Knockout Cell Lines are specially engineered cellular models that facilitate the study of gene function and regulation by completely abrogating the expression of the EEP-D1 gene. This gene plays a crucial role in various biological processes, including cellular signaling, metabolism, and immune responses. The knockout methodology employed in creating these cell lines utilizes CRISPR-Cas9 technology, which precisely targets and edits the EEP-D1 locus, ensuring effective gene disruption while minimizing off-target effects.
The primary function of EEP-D1 Gene Knockout Cell Lines is to serve as a robust platform for researchers investigating the biological implications of EEP-D1 in various contexts, such as cancer biology, pharmaceuticals, and genetic disorders. By eliminating the gene's function, researchers are better positioned to observe the resulting phenotypic changes, elucidating the gene's role in key cellular pathways and its impact on overall cellular physiology.
From a scientific standpoint, these knockout cell lines are invaluable for both basic and applied research. They enable the exploration of therapeutic targets and biomolecular interactions, which is essential for developing novel treatments for diseases linked to EEP-D1 dysregulation. Additionally, the application of these cell lines extends into drug screening and validation, making them a practical tool in the preclinical stage of therapeutic development.
The specific advantages of EEP-D1 Gene Knockout Cell Lines include their high specificity, reproducibility, and ease of use compared to traditional gene silencing methods such as RNA interference. Unlike transient knockdown techniques that can yield inconsistent results, these stable knockout lines provide a reliable foundation for longitudinal studies. Furthermore, as the lines maintain their altered state through numerous passages, they are favorable for high-throughput applications that require consistent performance.
For researchers and clinicians, investing in EEP-D1 Gene Knockout Cell Lines can dramatically accelerate the pace of discovery and deepen the understanding of EEP-D1's functions within various biological frameworks. Our company prides itself on its commitment to delivering high-quality genetic models and has a proven track record in the field of cellular engineering. We leverage the latest technologies to ensure that our products meet the highest standards of reliability and precision, making us a trusted partner in advancing your research goals.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.